TY - JOUR T1 - Tuberculosis in immunosuppressed patients JO - Enfermedades Infecciosas y Microbiología Clínica (English Edition) T2 - AU - Machuca,Isabel AU - Vidal,Elisa AU - de la Torre-Cisneros,Julián AU - Rivero-Román,Antonio SN - 2529993X M3 - 10.1016/j.eimce.2018.04.009 DO - 10.1016/j.eimce.2018.04.009 UR - https://www.elsevier.es/en-revista-enfermedades-infecciosas-microbiologia-clinica-english-428-articulo-tuberculosis-in-immunosuppressed-patients-S2529993X18301242 AB - Tuberculosis (TB) is one of the most significant infections in immunosuppressed patients due to its high frequency and high morbidity and mortality. TB is the leading cause of death among HIV-infected patients. The diagnosis and early treatment of latent tuberculosis infection is vital to preventing it progression to disease. Similarly, the early diagnosis of TB is key to improving the prognosis of patients and preventing its transmission. The clinical expression of TB in immunosuppressed patients is conditioned by the patient's degree of immunosuppression. It is important to keep this peculiarity in mind so as not to delay the diagnosis of suspected TB. TB treatment is basically the same in immunosuppressed patients as in the general population and any differences mainly derive from pharmacological interactions. We examined the diagnosis and treatment of TB and latent tuberculosis infection in immunosuppressed patients. ER -